Kuros Biosciences AG
OTC:CSBTF

Watchlist Manager
Kuros Biosciences AG Logo
Kuros Biosciences AG
OTC:CSBTF
Watchlist
Price: 38.34 USD Market Closed
Market Cap: 1.4B USD

Operating Margin
Kuros Biosciences AG

-1.8%
Current
-32%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1.8%
=
Operating Profit
-2.1m
/
Revenue
118.4m

Operating Margin Across Competitors

No Stocks Found

Kuros Biosciences AG
Glance View

Market Cap
1.5B USD
Industry
Biotechnology

Kuros Biosciences Ltd. engages in the discovery, development and prospective commercialization of a new class of biopharmaceutical products that are intended for use in the treatment and prevention of chronic diseases. The company is headquartered in Schlieren, Zuerich and currently employs 58 full-time employees. The company went IPO on 2002-10-29. Immunodrugs are therapeutic vaccines intended for treating and preventing common chronic diseases, such as hypertension, nicotine addiction, allergic diseases, asthma, malignant melanoma and Alzheimer's disease. They are designed to instruct the patient's immune system to produce desired therapeutic antibody or T cell responses that modulate chronic disease processes. The firm has built a pipeline of different Immunodrug candidates, of which five are in clinical development. Its Immunodrug candidates are developed both in-house and together with Novartis, Pfizer and Pfizer Animal Health, among others. The firm has two subsidiaries: a wholly-owned Proteome Therapeutics GmbH and minority owned BioSupport AG.

CSBTF Intrinsic Value
50.38 USD
Undervaluation 24%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1.8%
=
Operating Profit
-2.1m
/
Revenue
118.4m
What is the Operating Margin of Kuros Biosciences AG?

Based on Kuros Biosciences AG's most recent financial statements, the company has Operating Margin of -1.8%.

Back to Top